The cannabis team at Arnold & Porter is frequently instructed by funds, investors, financial institutions, and corporations in the pharmaceutical, consumer products, and cannabis segments seeking assistance with compliance, regulatory matters, and corporate transactions. The Washington DC-based practice is jointly headed up by Howard Sklamberg, an expert on FDA regulatory compliance who also represents clients in governmental investigations and enforcement matters, and Evelina Norwinski, who counsels manufacturer, distributor, retailer, and investor clients on the federal and state laws applicable to US cannabis operations. Life sciences and healthcare regulatory practice co-lead Daniel Kracov is known for assisting pharmaceutical and biotech companies with the challenges associated with the development, approval and marketing of FDA-regulated products.
Legal 500 redaktioneller Kommentar
- Profil
Auszeichnungen
Mandantenzufriedenheit
Kernmandanten
- Columbia Care
- National Retail Chain for Personal Care Products
- Large Dietary Supplement Company
- Family Office
- Chemical Supplier
- Cannabis Private Equity Company
- Bronx Defenders
Highlight-Mandate
- Advised and supported Columbia Care in the development of federal policy regulating medical cannabis and the scheduling of cannabis.
- Advised a National Retail Chain for Personal Care Products on federal and state laws governing personal care products containing hemp derivatives including the manufacture, import, packaging, labelling, and retail sale.
- Advised a Cannabis Private Equity Company on legality and FDA regulatory issues related to an investment in a company producing well-being products with certain psychoactive mushroom extracts.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Howard Sklamberg; Evelina Norwinski
Weitere Kernanwält*innen
Daniel Kracov